A Patch Free Treatment for Young Children With Amblyopia

Sponsor
University of Waterloo (Other)
Overall Status
Recruiting
CT.gov ID
NCT04086524
Collaborator
Retina Foundation of the Southwest (Other), McGill University (Other), Queensland University of Technology (Other)
160
2
3
32.6
80
2.5

Study Details

Study Description

Brief Summary

The purpose of this study is to test whether a binocular treatment can improve vision and motor function in young children with amblyopia. The proposed treatment is an animation series that has been modified so that different characters in the animation are presented to each eye. The contrast of the images shown to the amblyopic eye is higher than the contrast of the images shown to the fellow eye. The aim of the treatment is to promote co-operation between the two eyes and improve visual and motor outcomes. We will compare the benefits of this binocular treatment to patching, whereby the better eye is occluded with an eye patch for two hours per day to force the usage of the weaker eye. We hypothesize that the binocular treatment will improve vision and motor outcomes in young children with amblyopia, and that these improvements will be superior to any effects of patching.

Condition or Disease Intervention/Treatment Phase
  • Other: Binocular cartoon treatment at home
  • Other: Patching
  • Other: Binocular cartoon treatment in office
N/A

Detailed Description

This is a prospective study with study sites in Ontario, Canada (University of Waterloo); Quebec, Canada (University of McGill); Texas, United States of America (Retina Foundation of the Southwest); and Queensland, Australia (Queensland University of Technology). There are three study conditions. 1) binocular treatment at home, 2) binocular treatment in office and, 3) standard patching therapy.

Participants will be recruited from university-affiliated clinics and local clinical practices. Following full informed consent, participants will complete baseline testing to confirm eligibility and provide pre-treatment measurements of visual acuity, stereopsis, interocular suppression and motor function. Eligible participants will then be randomized to either binocular treatment or patching.

The treatment consists of dichoptically presented children's animations with all characters seen by the amblyopic eye and only a subset of characters seen by the fellow eye. Images shown to the amblyopic eye will be presented at 100% contrast and images presented to the fellow eye will be presented at 20% contrast on session 1 and contrast will increment by 10% of the prior session's contrast level for each subsequent session. Participants will complete 4 x 1-hour sessions per week for two weeks. After 2 weeks of treatment, participants will be offered the opportunity to complete an additional 2 weeks (8 hours) of treatment. Treatment will take place in the home or in-office depending on the study site.

The control group will patch for 2 hours every day, at home, for 2 weeks. A calendar will be provided (to both groups) in order for parents to track compliance. After 2 weeks of patching, participants in the control group have the option to crossover to the treatment group for an additional 2 weeks.

The primary analysis will compare visual acuity improvements from baseline between the binocular treatment and patching groups after 2 weeks of treatment. Secondary analyses will include comparisons of binocular vision and motor function outcomes between the binocular treatment and patching groups, comparisons of at-home vs. in-office binocular treatment outcomes and an evaluation of crossover effects.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
160 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
TREATMENT = 2 weeks of treatment (additional 2 weeks if they agree) CONTROL = 2 weeks patching, 2 weeks treatmentTREATMENT = 2 weeks of treatment (additional 2 weeks if they agree) CONTROL = 2 weeks patching, 2 weeks treatment
Masking:
Single (Outcomes Assessor)
Masking Description:
Study team members measuring outcome variables will be masked to treatment group.
Primary Purpose:
Treatment
Official Title:
A Patch Free Treatment for Young Children With Amblyopia
Actual Study Start Date :
Jan 13, 2020
Anticipated Primary Completion Date :
Oct 1, 2022
Anticipated Study Completion Date :
Oct 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Binocular cartoon treatment at home

Participants will view a dichoptic binocular cartoon (provided by BBC) on the Nintendo 3DS-XL at home. They will continue to watch the cartoon for 60 minutes, 4 times a week, for 2 weeks. After 2 weeks, they will be given the option to continue for an additional 2 weeks (total of 4 weeks). Watching the cartoon does not require any special glasses. They will discontinue patching during this time.

Other: Binocular cartoon treatment at home
see arm description.

Active Comparator: Control group

Participants will patch for 2 hours every day at home. After 2 weeks, they will be given the option to crossover to the teratment group for an additional 2 weeks (total of 4 weeks). Patching is a common treatment for amblyopia, often considered the "golden standard." It is the most common comparison as a "control" group in amblyopia and vision therapy literature.

Other: Patching
see arm description
Other Names:
  • occlusion therapy
  • penalization
  • Experimental: Binocular cartoon treatment in office

    Participants will view a dichoptic binocular cartoon (provided by BBC) on the Nintendo 3DS-XL in office. They will continue to watch the cartoon for 60 minutes, 4 times a week, for 2 weeks. After 2 weeks, they will be given the option to continue for an additional 2 weeks (total of 4 weeks). Watching the cartoon does not require any special glasses. They will discontinue patching during this time.

    Other: Binocular cartoon treatment in office
    see arm description.

    Outcome Measures

    Primary Outcome Measures

    1. Visual acuity [2 weeks]

      Change in visual acuity, measured in logMAR using an electronic HOTV test

    Secondary Outcome Measures

    1. Visual acuity [4 weeks]

      Change in visual acuity, measured in logMAR an electronic HOTV test

    2. Motor function [2 weeks]

      Change in motor function, measured using the Movement Assessment Battery for Children-2 (version 2)

    3. Stereopsis [2 weeks]

      Change in stereopsis, measured using the Randot Preschool Stereoacuity Test

    4. Treatment adherence [4 weeks]

      Self-reported amount of time spent viewing the cartoon or patching compared to amount of prescribed time

    5. Treatment adherence [2 weeks]

      Self-reported amount of time spent viewing the cartoon or patching compared to amount of prescribed time

    6. Stereopsis [4 weeks]

      Change in stereopsis, measured using the Randot Preschool Stereoacuity Test

    7. Motor function [4 weeks]

      Change in motor function, measured using the Movement Assessment Battery for Children-2 (version 2)

    8. Interocular suppression [2 weeks]

      Change in interocular suppression measured using the Worth 4 dot test

    9. Interocular suppression [4 weeks]

      Change in interocular suppression measured using the Worth 4 dot test

    10. Interocular contrast balance [2 weeks]

      Change in interocular contrast balance measured using a dichoptic letter chart

    11. Interocular contrast balance [4 weeks]

      Change in interocular contrast balance measured using a dichoptic letter chart

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    36 Months to 83 Months
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Aged 3-5.9 years old (36-83 months at the time of registration)

    • Confirmed diagnosis of amblyopia

    • Best-corrected visual acuity of 20/32 - 20/100 in the amblyopic eye

    • Best-corrected visual acuity of 20/16 - 20/40 in fellow eye for ages 3-4, and 20/16-20/32 for ages 5-5.9

    • Interocular difference in visual acuity of 3 lines or greater

    • If anisometropic, anisometropia (≥1.00D)

    • Wearing glasses for 8+ weeks + no change in VA w/ glasses for 4-6 weeks

    • Must be able to experience simultaneous perception when viewing the binocular treatment stimuli with an appropriate interocular contrast offset

    • Doctor and parent must be willing to forego patching/drops for 4 week study period

    Exclusion Criteria:
    • strabismus

    • Diagnosed eye disease or visual disorder other than amblyopia or anisometropia

    • 8 weeks premature

    • Diagnosed or suspected developmental delay (eg. learning disability, autism, Down syndrome)

    • Diagnosed systemic disease (eg. diabetes, lupus, albinism)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Retina Foundation of the Southwest Dallas Texas United States 75231
    2 Queensland University of Technology Brisbane Queesnland Australia 4000

    Sponsors and Collaborators

    • University of Waterloo
    • Retina Foundation of the Southwest
    • McGill University
    • Queensland University of Technology

    Investigators

    • Principal Investigator: Ben Thompson, PhD, University of Waterloo

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Ben Thompson, Professor, University of Waterloo
    ClinicalTrials.gov Identifier:
    NCT04086524
    Other Study ID Numbers:
    • 12345
    • 3600-105
    First Posted:
    Sep 11, 2019
    Last Update Posted:
    Feb 15, 2022
    Last Verified:
    Feb 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Ben Thompson, Professor, University of Waterloo
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 15, 2022